Comparison of circuit patency and exchange rates between the original and generic versions of nafamostat mesylate in critically ill adults receiving continuous renal replacement therapy
Background Nafamostat mesylate is widely used as an anticoagulant in continuous renal replacement therapy (CRRT). The generic versions of nafamostat mesylate have identical main components to the original product. However, it is questionable whether the generic versions have the same efficacy as the...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Kosin University College of Medicine
2023-03-01
|
| Colección: | Kosin Medical Journal |
| Materias: | |
| Acceso en línea: | http://www.kosinmedj.org/upload/pdf/kmj-22-137.pdf |